Obstetric outcome of patients with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization-embryo transfer - PubMed (original) (raw)
Obstetric outcome of patients with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization-embryo transfer
Kwang Yul Cha et al. Fertil Steril. 2005 May.
Free article
Abstract
Objective: To assess the obstetric outcome of pregnancies resulting from in vitro maturation (IVM) and IVF-ET of immature oocytes retrieved from women with polycystic ovary syndrome (PCOS).
Design: Prospective observational study.
Setting: University fertility clinic.
Patient(s): One hundred thirty-nine women undergoing 203 IVM treatment cycles.
Intervention(s): Immature oocyte recovery from unstimulated ovaries. In vitro oocyte maturation and fertilization. Fresh ET and assessment of obstetric outcomes in the pregnant women.
Main outcome measure(s): Pregnancy and obstetric outcome.
Result(s): Forty-one pregnancies were obtained in 187 ETs, resulting in a pregnancy rate of 21.9%. Except for three patients lost to follow-up in these pregnancies, the abortion and live birth rates were 36.8% (14 of 38) and 63.2% (24 of 38), respectively. The mean (+/-SD) gestational age and birth weight at delivery for singletons were 38.4 +/- 2.0 weeks (range, 33-41.6 weeks) and 3,252 +/- 516 g (1,750-4,100 g), respectively. For twins these were 36.7 +/- 1.9 weeks (34.6-39 weeks) and 2,361 +/- 304 g (1,900-2,990 g), respectively. Pregnancy complications occurred in five patients (13.2%); these included preterm labor (n = 3) and placenta previa (n = 2). Two patients (5.3%) had a major congenital anomaly diagnosed by ultrasonography.
Conclusion(s): The abortion rate, gestational age and birth weight at delivery, and obstetric complications of pregnancies conceived by IVM-ET in women with PCOS were comparable with those of other women with PCOS being treated by conventional IVF-ET. In vitro maturation followed by IVF-ET seems to be a useful treatment option for women with PCOS, thus avoiding the risk of ovarian hyperstimulation syndrome.
Similar articles
- Exposure to human chorionic gonadotropin during in vitro maturation does not improve the maturation rate and developmental potential of immature oocytes from patients with polycystic ovary syndrome.
Ge HS, Huang XF, Zhang W, Zhao JZ, Lin JJ, Zhou W. Ge HS, et al. Fertil Steril. 2008 Jan;89(1):98-103. doi: 10.1016/j.fertnstert.2007.02.021. Epub 2007 May 24. Fertil Steril. 2008. PMID: 17524398 Clinical Trial. - [Outcome of pregnancy in women with polycystic ovary syndrome treated by in vitro maturation of immature oocytes].
Zhao JZ, Chen X, Wang PY, Zhou W, Lin JJ, Zhang W, Huang XF, Lin WQ, Yang HY, Chen Y. Zhao JZ, et al. Zhonghua Fu Chan Ke Za Zhi. 2009 Jun;44(6):409-12. Zhonghua Fu Chan Ke Za Zhi. 2009. PMID: 19953938 Chinese. - Outcome of intracytoplasmic sperm injection in patients with polycystic ovary syndrome or isolated polycystic ovaries.
Esinler I, Bayar U, Bozdag G, Yarali H. Esinler I, et al. Fertil Steril. 2005 Oct;84(4):932-7. doi: 10.1016/j.fertnstert.2005.04.028. Fertil Steril. 2005. PMID: 16213846 - In vitro maturation for patients with polycystic ovary syndrome.
Reinblatt SL, Buckett W. Reinblatt SL, et al. Semin Reprod Med. 2008 Jan;26(1):121-6. doi: 10.1055/s-2007-992932. Semin Reprod Med. 2008. PMID: 18181090 Review. - In-vitro maturation of eggs: is it really useful?
Suikkari AM, Söderström-Anttila V. Suikkari AM, et al. Best Pract Res Clin Obstet Gynaecol. 2007 Feb;21(1):145-55. doi: 10.1016/j.bpobgyn.2006.09.003. Epub 2007 Feb 8. Best Pract Res Clin Obstet Gynaecol. 2007. PMID: 17291833 Review.
Cited by
- Resveratrol treatment during goat oocytes maturation enhances developmental competence of parthenogenetic and hand-made cloned blastocysts by modulating intracellular glutathione level and embryonic gene expression.
Mukherjee A, Malik H, Saha AP, Dubey A, Singhal DK, Boateng S, Saugandhika S, Kumar S, De S, Guha SK, Malakar D. Mukherjee A, et al. J Assist Reprod Genet. 2014 Feb;31(2):229-39. doi: 10.1007/s10815-013-0116-9. Epub 2013 Dec 4. J Assist Reprod Genet. 2014. PMID: 24305840 Free PMC article. - Effect of in vitro maturation of mouse oocytes on the health and lifespan of adult offspring.
Eppig JJ, O'Brien MJ, Wigglesworth K, Nicholson A, Zhang W, King BA. Eppig JJ, et al. Hum Reprod. 2009 Apr;24(4):922-8. doi: 10.1093/humrep/den466. Epub 2009 Jan 16. Hum Reprod. 2009. PMID: 19151027 Free PMC article. - The effect of human cumulus cells on the maturation and developmental potential of immature oocytes in ICSI cycles.
Zhang A, Xu B, Sun Y, Lu X, Niu Z, Chen Q, Feng Y, Xu C. Zhang A, et al. J Assist Reprod Genet. 2012 Apr;29(4):313-9. doi: 10.1007/s10815-012-9712-3. Epub 2012 Feb 22. J Assist Reprod Genet. 2012. PMID: 22354726 Free PMC article. - Ageing and ovarian stimulation modulate the relative levels of transcript abundance of oocyte DNA repair genes during the germinal vesicle-metaphase II transition in mice.
Horta F, Ravichandran A, Catt S, Vollenhoven B, Temple-Smith P. Horta F, et al. J Assist Reprod Genet. 2021 Jan;38(1):55-69. doi: 10.1007/s10815-020-01981-6. Epub 2020 Oct 17. J Assist Reprod Genet. 2021. PMID: 33067741 Free PMC article. - Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence.
Qiao J, Feng HL. Qiao J, et al. Hum Reprod Update. 2011 Jan-Feb;17(1):17-33. doi: 10.1093/humupd/dmq032. Epub 2010 Jul 16. Hum Reprod Update. 2011. PMID: 20639519 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical